Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × Glucose × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasm Metastasis 3 Breast Neoplasms 3 Ovarian Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Glioma 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain 1 Neoplasms 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Hypothyroidism 1 Hyperphagia 1 Hepatic Encephalopathy 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Goiter 1 Glioblastoma 1 Emergencies 1 Critical Illness 1

Interventions

Fentanyl 24 Analgesia 19 Acupuncture Therapy 17 Morphine 16 Surveys and Questionnaires 15 Zoledronic Acid 13 Oxycodone 13 Therapeutics 12 Acetaminophen 12 Radiotherapy 11 Lidocaine 11 Ketamine 11 Hydromorphone 11 Psychiatric Rehabilitation 10 Methadone 10 Ibandronic Acid 10 Bupivacaine 9 Ropivacaine 8 nabiximols 7 Analgesics, Opioid 7 Early Intervention, Educational 6 Water 5 Tapentadol 5 Pregabalin 5 Methods 5 Docetaxel 5 Cryotherapy 5 Cryosurgery 5 Yoga 4 Therapeutic Touch 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed

33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡